IPO Outlook: CoLucid Offers Hope For Migraine Sufferers
April 29, 2015 at 08:20 AM EDT
Headache combatant CoLucid Pharmaceuticals (NASDAQ: CLCD) is three days from going public Friday, May 1. The biopharmaceutical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.